Purchase disclosed
Ramiro G. Peru
Director
Common Stock
- Reported value
- $366.05K
- Reported price
- $366.05 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Elevance Health, Inc.
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Director
Common Stock
President and CEO
Common Stock
President and CEO
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Common StockPurchase | 1,000$366.05 / share | $366.05K | Jul 17Filed Jul 17 · 0d later | SEC filing |
| President and CEO | Common StockPurchase2 trades | 2,725avg $367.79 / share | $1M | Jul 17Filed Jul 17 · 0d later | 2 filings
|
$752,554 of common-equity purchase value after transaction-age decay across 180 days.
2 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.
At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Elevance Health, Inc. Common Stock · Stock
The filing reports a purchase for the member.
Elevance Health, Inc. Common Stock · Stock
The filing reports a purchase for a joint account.
Markwayne MullinReporting Senate member